PUBLISHER: 360iResearch LLP | PRODUCT CODE: 1056254
PUBLISHER: 360iResearch LLP | PRODUCT CODE: 1056254
The Global Single Cell Analysis Market size was estimated at USD 4,091.89 million in 2020 and expected to reach USD 4,516.21 million in 2021, at a CAGR 10.80% to reach USD 8,390.26 million by 2027.
The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2019 are considered historical years, 2020 as the base year, 2021 as the estimated year, and years from 2022 to 2027 are considered the forecast period.
Market Segmentation & Coverage:
This research report categorizes the Single Cell Analysis to forecast the revenues and analyze the trends in each of the following sub-markets:
Based on Product, the market was studied across Consumables and Instruments. The Consumables is further studied across Assay Kits and Reagents. The Instruments is further studied across Automated Cell Counters, Automated Instruments, Cell Microarrays, Flow cytometers, Hemocytometers, High-content Screening System, Manual Instruments, Microscopes, Next Generation Sequencing, and PCR Systems.
Based on Application, the market was studied across Cancer, Immunology, In-vitro fertilization, Neurology, Non-invasive prenatal diagnosis, and Stem cell.
Based on End-user, the market was studied across Academic & Research Laboratories, Biotechnology and Pharmaceutical Companies, and Hospitals and Diagnostic Laboratories.
Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.
Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.
Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.
FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Single Cell Analysis Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.
Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.
Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Single Cell Analysis Market, including 10x Genomics, Inc., Beckman Coulter, Inc., Becton, Dickinson & Company, BGI Genomics Co., Ltd, Bio-Rad Laboratories, Inc., Cisco Systems, Inc., Danaher Corporation, Fluidigm Corporation, General Electric Company, Illumina, Inc., LumaCyte LLC, Luminex Corporation, MedGenome Inc., Menarini Silicon Biosystems S.p.A., Merck KGaA, Novogene Corporation, PerkinElmer Inc., Sartorius AG, Takara Bio USA Holdings, Inc., and Thermo Fisher Scientific, Inc..
The report provides insights on the following pointers:
The report answers questions such as: